NZ547178A - Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol - Google Patents

Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol

Info

Publication number
NZ547178A
NZ547178A NZ547178A NZ54717804A NZ547178A NZ 547178 A NZ547178 A NZ 547178A NZ 547178 A NZ547178 A NZ 547178A NZ 54717804 A NZ54717804 A NZ 54717804A NZ 547178 A NZ547178 A NZ 547178A
Authority
NZ
New Zealand
Prior art keywords
salbutamol
isomer
use according
beta
mammal
Prior art date
Application number
NZ547178A
Other languages
English (en)
Inventor
Gunnar A K Aberg
Original Assignee
Alteragon Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alteragon Pty Ltd filed Critical Alteragon Pty Ltd
Publication of NZ547178A publication Critical patent/NZ547178A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Detergent Compositions (AREA)
NZ547178A 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol NZ547178A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52437603P 2003-11-20 2003-11-20
US10/987,665 US20050113456A1 (en) 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birds
PCT/US2004/037966 WO2005051092A2 (en) 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birds

Publications (1)

Publication Number Publication Date
NZ547178A true NZ547178A (en) 2008-06-30

Family

ID=34595131

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ547178A NZ547178A (en) 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol

Country Status (8)

Country Link
US (2) US20050113456A1 (cg-RX-API-DMAC7.html)
EP (1) EP1684593A4 (cg-RX-API-DMAC7.html)
JP (1) JP2007515402A (cg-RX-API-DMAC7.html)
AU (1) AU2004292416B2 (cg-RX-API-DMAC7.html)
CA (1) CA2545559A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ547178A (cg-RX-API-DMAC7.html)
WO (1) WO2005051092A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200604077B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106075449A (zh) 2005-07-14 2016-11-09 尼奥塞蒂克斯公司 用于局部脂肪组织治疗的持续释放的增强性脂肪分解性制剂
US20070264313A1 (en) * 2006-05-12 2007-11-15 Musser Robert E Methods and compositions relating to animal dietary acids
AU2007313077B2 (en) * 2006-10-17 2011-06-02 Neothetics, Inc. Methods, compositions, and formulations for the treatment of thyroid eye disease
WO2009073051A1 (en) * 2007-12-03 2009-06-11 Bridge Pharma, Inc. Use of rr/sr-ractopamine
WO2010027259A1 (en) 2008-09-02 2010-03-11 N.V. Nutricia Nutritional compositions with coated lipid globules
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
GB2487868B (en) * 2010-01-15 2014-12-10 Neothetics Inc Lyophilized cake formulations
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
BR112013012994A2 (pt) * 2010-11-24 2016-09-13 Lithera Inc formulações monoterapêuticas de beta-agonista de longa duração, lipofílicas e seletivas e métodos para o tratamento cosmético da adiposidade e saliência de contorno
DK3091973T3 (en) 2013-11-01 2018-11-05 Nutricia Nv LIPID COMPOSITION FOR IMPROVING BODY COMPOSITION DURING GROWTH
KR102273533B1 (ko) * 2015-06-15 2021-07-06 삼성전자 주식회사 무선 통신 시스템에서 서비스 제공 방법 및 장치
PL3574771T3 (pl) 2015-10-15 2023-03-13 N.V. Nutricia Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu
BR112019011809B1 (pt) 2016-12-09 2023-02-28 N.V. Nutricia Uso de lipídeo na forma de glóbulos lipídicos

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085514A3 (en) * 1982-01-28 1984-02-29 Beecham Group Plc Compositions comprising a beta-antagonist and a beta-agonist, their preparation, and their use in treating obese humans and animals
GB8604134D0 (en) * 1986-02-19 1986-03-26 Glaxo Group Ltd Veterinary preparations
IE60964B1 (en) * 1986-12-11 1994-09-07 Roussel Uclaf Zootechnical compositions containing a beta-adrenergic
US5147869A (en) * 1986-12-11 1992-09-15 Roussel Uclaf Zootechnical compositions
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
FR2642075B1 (fr) * 1989-01-25 1991-04-26 Pasteur Institut Polypeptides ayant une activite de recepteur (beta)-adrenergique chez l'homme, impliques dans la reponse lipolytique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substance active sur ces polypeptides
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
ES2085468T3 (es) * 1990-01-05 1996-06-01 Sepracor Inc Albuterol r(-) opticamente puro para tratar el asma.
US5362755A (en) * 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
JP3358631B2 (ja) * 1993-05-17 2002-12-24 三菱瓦斯化学株式会社 メタノ−ルの脱水素方法
US5545745A (en) * 1994-05-23 1996-08-13 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5399765A (en) * 1994-05-23 1995-03-21 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5698199A (en) * 1995-03-10 1997-12-16 Kao Corporation Lipolysis acceleration method
US5708036A (en) * 1996-01-29 1998-01-13 Pesterfield, Jr.; E. Charles Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
EP0979081A4 (en) * 1997-04-30 2003-05-02 Bridge Pharma Inc COMPOSITION AND METHODS USING EUTOMER
US7767708B2 (en) * 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
US6683115B2 (en) * 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
GB0030171D0 (en) * 2000-12-11 2001-01-24 Cipla Ltd Process for preparing isomers of salbutamol

Also Published As

Publication number Publication date
AU2004292416A1 (en) 2005-06-09
CA2545559A1 (en) 2005-06-09
EP1684593A4 (en) 2010-02-10
WO2005051092A3 (en) 2006-04-06
US20080020019A1 (en) 2008-01-24
AU2004292416B2 (en) 2010-01-28
EP1684593A2 (en) 2006-08-02
ZA200604077B (en) 2009-11-29
JP2007515402A (ja) 2007-06-14
WO2005051092A2 (en) 2005-06-09
US20050113456A1 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
US20080020019A1 (en) Method of decreasing fat deposits and body weight in mammals and birds
US8445542B2 (en) Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals
AU2008331928B2 (en) Use of RR/SR-ractopamine
CA2039194C (en) Uses of l-deprenyl and compositions for same
US6110974A (en) Methods of accelerating muscle growth and improving feed efficiency in animals by using optically pure eutomers of adrenergic beta-2 receptor agonists, and food supplements containing the same
US5541188A (en) Therapeutic applications of beta-adrenergic agonists
JP2007515402A5 (cg-RX-API-DMAC7.html)
EP0662324A1 (en) Use of beta-adrenergic agonists for treating loss of function of striated muscles
US20080070990A1 (en) Use of ractopamine enantiomers
EP1787529A2 (en) Composition and methods using an eutomer
MXPA99009783A (en) Composition and methods using an eutomer
WO2009020620A1 (en) Synergisms between repartitioning and immunomodulating compounds
CN1882320A (zh) 减少哺乳动物和鸟类的脂肪堆积物和体重的方法
HK1011611B (en) Use of l-deprenyl for retarding age dependent deterioration of the immune system function in mammals

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: ALTERAGON PTY LTD, AU

Free format text: OLD OWNER(S): STIRLING PRODUCTS LIMITED

PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 NOV 2015 BY WRAYS

Effective date: 20150112

LAPS Patent lapsed